Glaxosmithkline Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹938.44 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.71 per cent from ₹995.30 crore. This corresponds to a year-on-year *(YoY) growth of 16.55 per cent.
Operating Profit
Operating Profit stands at ₹295.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.80 per cent from ₹350.93 crore. This corresponds to a year-on-year *(YoY) growth of 17.64 per cent.
PBDT
PBDT stands at ₹338.29 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.42 per cent from ₹386.27 crore. This corresponds to a year-on-year *(YoY) growth of 14.87 per cent.
Profit Before Tax
Profit Before Tax stands at ₹322.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.58 per cent from ₹373.10 crore. This corresponds to a year-on-year *(YoY) growth of 15.58 per cent.
Net Profit
Net Profit stands at ₹237.18 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.64 per cent from ₹277.86 crore. This represents a 15.69 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Glaxosmithkline Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Glaxosmithkline Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Glaxosmithkline Pharmaceuticals Ltd Research Reports
Glaxosmithkline Pharmaceuticals Ltd Financial Reports
Glaxosmithkline Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Glaxosmi. Pharma | 0.39% | -2.41% | 6.47% | 6.45% | -1.02% | -3.54% |
| Abbott India | -0.66% | -0.31% | 2.42% | 0.01% | 1.70% | -15.82% |
| Anthem Bioscienc | 1.18% | 1.24% | 11.39% | 7.24% | 24.25% | 11.56% |
| Ipca Labs. | 0.41% | 0.79% | -2.84% | 13.28% | 21.76% | 29.88% |
| Ajanta Pharma | 1.19% | -0.76% | 4.08% | 13.80% | 20.56% | 31.74% |
| Gland Pharma | -0.65% | 0.90% | 4.87% | 35.43% | 38.05% | 34.29% |
| Emcure Pharma | 2.12% | 0.54% | 9.20% | 17.79% | 30.70% | 42.41% |
Company Info
Company Information
Chairman & Non Executive Dir. : Renu S. Karnad
Managing Director : Bhushan Akshikar
Independent Non Exe. Director : Manu Anand
Independent Non Exe. Director : Sunita Maheshwari
Independent Non Exe. Director : Somasundaram Palamadairamaswamy
Independent Non Exe. Director : Anup Wadhawan
Whole Time Director & CFO : Ronojit Biswas
VP / Company Secretary / Compliance Officer : A A Nadkarni
Non Executive Director : Karine J F Natland